0R2S.L - Stryker Corporation

LSE - LSE Prezzo differito. Valuta in USD.

Stryker Corporation

2825 Airview Boulevard
Kalamazoo, MI 49002
United States
269 385 2600

Impiegati a tempo pieno51.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Kevin A. LoboChairman, CEO & Pres3,31M33,14M1965
Mr. Glenn S. BoehnleinVP & CFO1,43MN/D1962
Mr. Viju S. MenonGroup Pres of Global Quality & Operations1,05MN/D1968
Mr. J. Andrew PierceGroup Pres of MedSurg & Neurotechnology1,32MN/D1974
Mr. Spencer S. StilesGroup Pres of Orthopaedics & Spine1,28M2,13M1977
Mr. William E. Berry Jr.VP & Chief Accounting OfficerN/DN/D1966
Mr. Robert C. CohenCTO and VP of Global R&D - Joint ReplacementN/DN/DN/D
Mr. Alan DouvilleVP, Chief Information Officer & Chief Information Security OfficerN/DN/DN/D
Mr. Jason BeachVP of Investor RelationsN/DN/DN/D
Mr. Robert S. FletcherVP & Chief Legal OfficerN/DN/D1971
Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.


Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Governance aziendale

L'ISS Governance QualityScore di Stryker Corporation al 1 giugno 2023 è 8. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 6; diritti degli azionisti: 6; retribuzione: 4.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.